IKONICS Corporation
Annual Report 2013

Plain-text annual report

2013+ ANNUAL REPORT ® Corporation NASDAQ LISTED: IKNX CONTENTS COMPANY OVERVIEW IKONICS is a corporation with four important technology platforms: Ultraviolet (UV) reactive chemistry, film coating and construction, industrial inkjet printing and technical powder blasting. IKONICS combines these technologies in various ways to create products and services for screen printers, manufacturers of awards and trophies, manufacturers of textured molds for plastic injection, and the custom machining of advanced composite materials and electronic wafers. IKONICS customer base includes over 25,000 end-users of its screen printing and awards and trophy products, suppliers to the worldwide automotive industry, and major civilian and military electronics and aerospace companies. IKONICS products and services are used to manufacture products that range from T-shirts to the latest automobiles to the most advanced commercial and military aircraft. IKONICS key technologies are developed internally, and the Company believes it has a strong patent and trade secret position. All manufacturing is done in Duluth. This range of technologies, markets, and the Company’s strong financial condition makes IKONICS a very robust company, and the Company believes it is buffered against many of the vagaries of the market and the economy. IKONICS’ commitment to a range of new technologies gives the Company substantial growth potential. Letter to Shareholders............................................................................................1 Special Note Regarding Forward-Looking Statements..............................................2 Risk Factors..........................................................................................................2 Management’s Discussion and Analysis of Financial Condition and Results of Operations.........................................................5 Critical Accounting Policies and Estimates...............................................................5 Results of Operations.............................................................................................6 Market for Common Equity and Related Stockholder Matters...................................................................................8 Management’s Report............................................................................................8 Management’s Annual Report on Internal Control Over Financial Reporting.................................................................9 Report of Independent Registered Public Accounting Firm......................................................................... 9 Balance Sheets....................................................................................................10 Statements of Income..........................................................................................11 Statements of Stockholder’s Equity.......................................................................11 Statements of Cash Flows................................................................................... 12 Notes to Financial Statements..............................................................................13 Board of Directors/Corporate Officers...................................................................19 IKONICS Five-Year History.......................................................................Back Cover CORPORATE PROFILE 2013 Net Sales...................................................................................$17,491,408 Earnings per common share (diluted)...............................................................$0.34 Company founded...........................................................................................1952 Employees..........................................................................................................75 NASDAQ Symbol..............................................................................................IKNX Letter to SharehoLderS Important foundations for growth were laid at IKONICS in 2013. For the year, sales were $17,491,000. This is a 1% increase over 2012, while earnings fell by 2% to $682,000 or $0.34 per diluted share. I believe 2014 will be a better year for the following reasons: •In the first quarter, Ikonics Imaging shipped a very large initial stocking order, which will have a substantial effect on profits and sales for the quarter and the year. •Our Micro-Machining Aerospace business suffered the loss of a major customer in 2013. The division was also negatively impacted by high costs related to product development. In 2014, we will be transitioning to more profitable production parts. We are currently producing advanced composite parts for four customers and are in negotiations with others. This business is being driven primarily by the growth of the civilian aviation sector and its increasing use of composites. We are also in the development phase of a major defense project. We added technical staff in 2013, and in the first quarter of 2014 brought in a respected veteran of the aerospace industry to lead this business. Investment in high-quality people and advanced production equipment are costly, but I believe it is a path Ikonics must follow to grow and prosper in this high technology field. •Chromaline, our traditional technology for the screen print industry, continues to be a steady source of sales and profits and should benefit in 2014 from new products aimed at the touch screen and solar panel industries. I am also optimistic about further growth in sales to customers in China, particularly in the consumer electronics industry. •Our DTX business has been slow to develop due to technical issues, but we are now making a major effort in the 3D printing and prototyping arena, where our technology offers higher precision and larger format prints than are available with most other offerings in this market. Given these developments, in 2014, I anticipate a robust performance from our traditional businesses, a new focus on growth and profits in our aerospace business, and an exciting entry into the 3D printing market with our DTX technology. WILLIAM C. ULLAND Chairman, President & CEO March 20, 2014 1 1 SpeciaL note regarding forward-Looking StatementS This 2013 Annual Report contains forward looking statements within the meaning of the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended, relating to future events or the future financial performance of the Company. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward looking statements are only predictions or statements of intention subject to risks and uncertainties and actual events or results could differ materially from those projected. Forward- looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this 2013 Annual Report. Factors that could cause actual results to differ include the risks, uncertainties and other matters set forth below under the caption “Risk Factors” and the matters set forth under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” as well as those discussed in the Company’s filings with the Securities and Exchange Commission. riSk factorS The Company’s DTX and Micro-Machining initiatives involve new technologies that might not be executed successfully and might not achieve market acceptance, which would adversely affect the Company’s results of operation, financial condition and prospects. The Company’s DTX and Micro-Machining initiatives involve new and unproven technologies that might never achieve market acceptance. During 2012 and 2013, the Company generated operating losses in both its DTX and Micro-Machining segments. The Company’s ability for generating profits from these initiatives will depend on its products gaining market acceptance among customers, which cannot be guaranteed. The degree of market acceptance of any new products the Company develops will depend on a number of factors, including: •the Company’s ability to successfully develop its technologies and products to include the capabilities the Company intends; •the Company’s ability to accurately assess the functions and features customers desire; •the perceived effectiveness and price of the Company’s products compared to alternative products and technologies; •the development of new products and technologies by current competitors or new competitors that might enter the Company’s markets; and •the strength of the Company’s marketing and distribution functions. If new products that the Company develops do not have the capabilities the Company expects or fail to achieve an adequate level of acceptance by customers for any reason, then the Company’s Micro-Machining and DTX business units could fail to generate the revenues the Company expects and may not become profitable or sustain profitability. If the Company’s new products and technologies do not achieve market acceptance, the Company will not realize a return on its investments in its new business initiatives. The Company has invested, and plans to continue to invest, significant resources in its research and development efforts to develop technology for its Micro-Machining and DTX business units. The Company spent 3.7% of sales, or $649,000, on research and development in 2013, and 3.6% of sales, or $630,000, in 2012. A substantial portion of these investments was in the Company’s Micro-Machining and DTX initiatives. The Company plans to continue to invest significant resources in research and development on these initiatives in the foreseeable future. The Company believes successful execution of these initiatives is important for its ability to grow its revenues and profits. However, if the Company fails to generate its projected revenues in these business units, the Company’s investments in these areas would not generate the profits the Company expects and its results of operations, financial condition and prospects would be materially and adversely affected. Adverse changes to global economic conditions generally, and to the aerospace and automotive industries in particular, may harm the Company’s business. The prospects for economic growth in the United States and other countries remain uncertain and major economies where the Company conducts business could continue or return to recessionary conditions. Economic concerns and issues such as reduced access to capital for businesses may cause the Company’s customers to delay or reduce purchases of the Company’s products. Given the continued uncertainty concerning the global economy, the Company also faces risks that may arise from financial difficulties experienced by suppliers and customers, such as an inability to collect receivables or the continued operation of suppliers. The Company’s Micro-Machining segment focuses primarily on customers in the aerospace industry, and its DTX segment focuses primarily on customers in the automotive industry. The aerospace and automotive industries have experienced volatility in recent years in a manner similar to or greater than the global economy generally. If either or both these industries experiences difficulties that reduce demand for their products generally, the Company’s results of operations, financial condition and prospects would suffer. The Company faces risks related to sales to government subcontractors, including potential delays or cancellations of planned sales and additional regulatory compliance costs and obligations. The Company’s customers for its Micro-Machining business unit manufacture aerospace products, and the Company derives a portion of its revenue as a subcontractor to general contractors working for the U.S. government. As a government subcontractor, demand and payment for the Company’s products may be adversely affected by public sector budgetary cycles or funding authorizations. Any cancellation or delay of product orders would adversely affect the Company’s operating results and financial condition. In addition, government subcontractors are subject to oversight, including special rules on accounting, expenses, reviews and security. This additional oversight could increase the Company’s compliance costs and creates risk of a failure to comply with applicable rules and regulations. A failure to comply with these rules and regulations could result in termination of contracts, fines and suspensions, debarment from future government business or other penalties, any of which could adversely affect the Company’s business. 2 IKONICS CORPORATION | 2013 ANNUAL REPORTThe Company faces significant competition and expects to face increasing competition in many aspects of its businesses, which could cause operating results to suffer. The Company operates in highly competitive industries that experience rapid technological and market developments, changes in customer needs, and frequent product introductions and improvements, particularly with respect to the Micro- Machining and DTX businesses. If the Company is unable to anticipate and respond to these developments, its products or technologies could become uncompetitive or obsolete. Many of the Company’s competitors in the Micro-Machining and DTX fields are larger and better capitalized than the Company with longer operating histories. These advantages could allow the Company’s competitors to invest more in research and development and sales and marketing than the Company, which could make the competitive products more attractive or better known to consumers than the Company’s products. In addition, because there is rapid technological change in fields in which the Company operates, the Company could face competition from new sources in the future that customers find more attractive. The Company also could face increased competition in its traditional Chromaline Screen Print and IKONICS Imaging units. Capital costs for machinery necessary to operate in these industries have decreased in recent years, increasing the possibility that the Company will face new competitors. An increase in the amount of competition the Company faces, or a loss of competitiveness in any of the Company’s business units for any reason, could adversely affect its revenues and gross margins. The Company’s failure to comply with environmental laws and regulations could harm its business and results of operations. The manufacturing of the Company’s products requires the use of hazardous materials that are subject to a broad array of environmental laws and regulations. The Company’s failure to comply with these laws or regulations could result in: •regulatory penalties, fines and legal liabilities; •suspension of production; •alteration of manufacturing processes; and •restrictions on the Company’s operations or sales. The Company’s failure to manage the use, transportation, emissions, discharge, storage, recycling or disposal of hazardous materials could lead to increased costs or future liabilities. Environmental laws and regulations also could require the Company to acquire pollution abatement or remediation equipment, modify product designs or incur other expenses. Third parties may claim the Company infringes their intellectual property rights, which could harm the Company’s business. The Company may face claims that it infringes other parties’ intellectual rights. Regardless of a claim’s merit, claims that the Company’s products or processes infringe the intellectual property rights of others could cause the Company to incur large costs to respond to, defend, and resolve the claims, and they may divert the efforts and attention of management and technical personnel. As a result of any intellectual property rights infringement claims, the Company could be required to: •pay infringement claims; •stop manufacturing, using, or selling products or technology subject to infringement claims; •develop other products or technology not subject to infringement claims, which could be time-consuming, costly or impossible; or •license technology from the party claiming infringement, which license may not be available on commercially reasonable terms or at all. These actions could harm the Company’s competitive position, result in additional expenses, or require the Company to impair its assets. If the Company alters or stops production of affected items, its revenue could be harmed. The Company may be unable to enforce or protect its intellectual property rights, which may harm its ability to compete and may harm its business. The Company’s ability to enforce its patents, trademarks and other intellectual property rights is subject to general litigation risks, as well as uncertainty as to the enforceability of the Company’s intellectual property rights in various countries. If the Company seeks to enforce its rights, it could become subject to claims that its intellectual property rights are invalid, not enforceable, or licensed to the opposing party. The Company’s assertion of intellectual property rights also could result in the other party seeking to assert claims against the Company, which could harm the Company’s business. The Company’s inability to enforce its intellectual property rights for any reason could harm its competitive position and business. If the Company is unable to protect the confidentiality of its proprietary information and know-how, the value of its technology could be adversely affected. In addition to patented technology, the Company relies on unpatented proprietary technology, trade secrets, processes and know-how. The Company generally seeks to protect this information by confidentiality agreements with employees, consultants, advisors and third parties. These agreements may be breached, and the Company may not have adequate remedies for any such breach. In addition, the Company’s trade secrets may otherwise become known or be independently developed by competitors. To the extent that the Company’s employees, consultants or contractors use intellectual property owned by others in their work for the Company, disputes may arise as to the rights in related or resulting know-how and inventions. The Company operates a global business that exposes it to additional risks. The Company operates throughout the world, including in the United States, Europe and China. These international operations create a variety of risks and uncertainties, including: •rapid changes in government, economic and political policies and conditions, political or civil unrest or instability, terrorism or epidemics, •fluctuations in foreign currency exchange rates; •compliance with and changes in foreign laws and regulations, as well as U.S. laws affecting the activities of U.S. companies abroad, including the Foreign Corrupt Practices Act of 1977 (the “FCPA”), as amended; •different, complex and changing laws governing intellectual property rights, sometimes affording companies lesser protection in certain areas; •longer accounts receivable payment cycles and difficulties in collecting accounts receivable; •protectionist laws and business practices that favor local producers; and •potentially adverse tax consequences, including the complexities of foreign value added tax systems and restrictions on the repatriation of earnings. 3 3 The occurrence of any one of these risks could negatively affect the Company’s international business and, consequently, its results of operations generally. The Company faces risks related to sales through distributors and other third parties. During 2013, approximately 72% of the Company’s sales, including nearly all sales of its Chromaline products and nearly all of its International sales, were conducted through third parties. Using third parties for distribution exposes the Company to many risks, including competitive pressure, concentration, credit risk and compliance risks. Distributors may sell products that compete with the Company’s products, and the loss of a distributor could reduce the Company’s revenue. Distributors may face financial difficulties, including bankruptcy, which could harm the Company’s collection of accounts receivable and financial results. Violations of the FCPA or similar laws by distributors or other third-party intermediaries could have a material impact on the Company’s business. Failing to manage risks related to the Company’s use of distributors may reduce sales, increase expenses, and weaken its competitive position. Increases in prices and declines in the availability of raw materials could negatively impact the Company’s financial results. Raw materials needed to manufacture products are obtained from a limited number of suppliers and many of the raw materials are petroleum-based. Under normal market conditions, these raw materials are generally available on the open market from a variety of producers. While alternate supplies of most key raw materials are available, supplier production outages may lead to strained supply-demand situations for certain raw materials. The substitution of key raw materials could require the Company to identify new supply sources, or reformulate and retest products or processes. From time to time, the prices and availability of these raw materials may fluctuate, which could impair the Company’s ability to procure necessary materials, or increase the cost of manufacturing products. If the prices of raw materials increase in a short period of time, the Company may be unable to pass these increases on to its customers in a timely manner or at all, which could reduce its gross margins. Like most companies in the Company’s industries, the Company does not have long-term supply contracts for most of its key raw materials, which exacerbates the foregoing risks to the Company. If any of the Company’s present single or limited source suppliers become unavailable or inadequate, its customer relationships, results of operations and financial condition may be adversely affected. The Company acquires certain of its materials that are critical to its operations from a limited number of third parties. Should any of the Company’s current single or limited source suppliers become unavailable or inadequate, or impose terms unacceptable to the Company such as increased pricing terms, the Company could be required to spend a significant amount of time and expense to develop alternate sources of supply, and may not be successful in doing so on acceptable terms or at all. If the Company is unable to find a suitable supplier for a particular material, it could be required to modify its existing business processes or offerings to accommodate the situation. As a result, the loss of a single or limited source supplier could adversely affect the Company’s relationship with its customers and its results of operations and financial condition. The Company depends on two manufacturers to make and sell DTX printers. If the manufacturers ceased to make or sell DTX printers, or failed to meet quality standards, the Company’s financial results and prospects would be adversely affected. The Company relies on two companies to manufacture and sell DTX printers. If the manufacturers ceased to produce or devote resources to selling DTX printers, due to a change in company strategy, to focus on alternative initiatives, or for any other reason, the Company would need to find an alternative manufacturer and seller of DTX printers. Finding an alternative manufacturer and seller of DTX printers could result in additional costs and delays in growing the Company’s DTX business unit, which would adversely affect the Company’s financial results and prospects. In addition, if these manufacturers failed to produce DTX printers that satisfy the Company’s quality standards, the Company’s reputation with end users could be harmed and the Company could be forced to find a new manufacturer. Either of these results also would harm the Company’s business and prospects. The inability to attract and retain qualified personnel could adversely impact the Company’s business. Sustaining and growing the Company’s business depends on the recruitment, development and retention of qualified employees, including management and research and development personnel. The inability to recruit and retain key personnel or the unexpected loss of key personnel may adversely affect the Company’s operations. An active trading market for the Company’s shares of common stock may not develop. The Company’s common stock has been listed for trading on the Nasdaq Capital Market since 1999 and persistently has experienced limited trading volume. There can be no assurance that an active public market for the Company’s shares will develop or be sustained. The lack of an active trading market could adversely affect the price and liquidity of the Company’s common stock. The Company’s directors and officers own a large percentage of the Company’s common stock, which may allow them to collectively exert significant influence over substantially all matters requiring shareholder approval. As of December 31, 2013, the Company’s directors and officers collectively beneficially owned approximately 35.23% of its common stock outstanding as of that date. As a result, the Company’s directors and officers could exert significant influence over all matters requiring a shareholder vote, including the election of directors, amendments to the Company’s articles of incorporation, and extraordinary transactions such as mergers or going private transactions. These ownership positions may have the effect of delaying, deterring or preventing a change in control or a change in the composition of the Company’s board of directors. In addition, substantial sales of shares beneficially owned by our directors or officers could be viewed negatively by third parties and have a negative impact on the Company’s stock price. The price of the Company’s common stock may fluctuate significantly. The price of the Company’s common stock has, and could continue to, fluctuate substantially in a short period of time. The price of the Company’s common stock could vary for many reasons, including the following: 4 IKONICS CORPORATION | 2013 ANNUAL REPORT•future announcements concerning the Company or its competitors; •introduction of new products by the Company or its competitors, or the failure of the Company’s new products to meet expectations; •the commencement of, or developments to, litigation involving the Company; •quarterly variations in operating results, which the Company has experienced in the past and expects to experience in the future; management’S diScuSSion and anaLySiS of financiaL condition and reSuLtS of operationS The following management discussion and analysis focuses on those factors that had a material effect on the Company’s financial results of operations and financial condition during 2013 and 2012 and should be read in connection with the Company’s audited financial statements and notes thereto for the years ended December 31, 2013 and 2012, included herein. •business acquisitions or divestitures; or criticaL accounting poLicieS and eStimateS •changes to the global economy in general, and the aerospace and automotive markets in particular. In addition, stock markets in general have experienced price and volume fluctuations in recent years, fluctuations that sometimes have been unrelated to the operating performance of the affected companies. These broad market fluctuations may adversely affect the market price of the Company’s common stock. The market price of the Company’s common stock could decline below its current price and the market price of the Company’s shares may fluctuate significantly in the future. These fluctuations may be unrelated to the Company’s performance. The Company’s operating results and financial condition may fluctuate on a quarterly and annual basis. The Company’s operating results and financial condition may fluctuate from quarter to quarter and year to year, and could vary due to a number of factors, some of which are outside of the Company’s control. In addition, the Company’s actual or projected operating results may fail to match its past performance. The Company’s operating results and financial condition may fluctuate due to a number of factors, including those listed below and those identified throughout this “Risk Factors” section: •the failure of the Company’s new products to meet expectations; •changes to the costs of raw materials, especially petroleum-based materials; •the entry of new competitors into the Company’s markets whether by established companies or by new companies; •the geographic distribution of the Company’s sales; •changes in customer preferences or needs; •changes in the amount that the Company invests to develop or acquire new technologies; •delays between the Company’s expenditures to develop new technologies and products and the generation of sales related thereto; •changes in the Company’s pricing policies or those of its competitors; •changes in accounting rules and tax and other laws; and •general economic and industry conditions that affect customer demand and product development trends. Due to all of the foregoing factors and the other risks discussed in this “Risk Factors” section, you should not rely on quarter-to-quarter or year-to-year comparisons of the Company’s operating results as an indicator of future performance. The Company prepares its financial statements in conformity with accounting principles generally accepted in the United States of America. Therefore, the Company is required to make certain estimates, judgments and assumptions that the Company believes are reasonable based upon the information available. These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The accounting policies and estimates which IKONICS believes are the most critical to aid in fully understanding and evaluating its reported financial results include the following: Trade Receivables – The Company performs ongoing credit evaluations of its customers and adjusts credit limits based upon payment history and the customer’s current credit worthiness, as determined by review of the current credit information. The Company continuously monitors collections and payments from its customers and maintains a provision for estimated credit losses based upon historical experience and any specific customer collection issues that have been identified. While such credit losses have historically been within expectations and the provisions established, the Company cannot guarantee that it will continue to experience the same collection history that has occurred in the past. The general payment terms are net 30-45 days for domestic customers and net 30-90 days for foreign customers. A small percentage of the trade receivables balance is denominated in a foreign currency with no concentration in any given country. At the end of each reporting period, the Company analyzes the receivable balance for customers paying in a foreign currency. These balances are adjusted to each quarter or year end spot rate in accordance with FASB ASC 830, Foreign Currency Matters. Inventories – Inventories are valued at the lower of cost or market value using the last in, first out (LIFO) method. The Company monitors its inventory for obsolescence and records reductions from cost when required. Self-Funded Medical Insurance – Beginning in January 2012, the Company moved from a fully insured to a self-funded medical insurance plan. The Company contracted with an administrative service company or a “third party administrator” to supervise and administer the program and act as the Company’s fiduciary and representative. The Company has reduced its risk under this self-funded plan by purchasing both specific and aggregate stop-loss insurance coverage for individual claims and total annual claims in excess of prescribed limits. The Company records estimates for claim liabilities based on information provided by the third-party administrators, historical claims experience, the life cycle of claims, expected costs of claims incurred but not paid, and expected costs to settle unpaid claims. The Company regularly monitors its estimated insurance-related liabilities. Actual claims experience may differ from the Company’s estimates. Costs related to the administration of the plan and related claims are expensed as incurred. The total liability for self-funded medical insurance was $55,000 as of December 31, 2013 and is included within other accrued liabilities in the consolidated balance sheet. 5 5 Income Taxes – At December 31, 2013, the Company had net current deferred tax assets of $150,000 and net noncurrent deferred tax liabilities of $527,000. The deferred tax assets and liabilities result primarily from temporary differences in property and equipment, accrued expenses, and inventory reserves. At December 31, 2013, the Company recorded a valuation allowance of $326,000, of which $17,000 is related to a Minnesota research and development credit and $309,000 pertains to a U.S. federal capital loss carryovers. The Company believes it is more likely than not that these deferred tax assets will not be utilized in future years. The capital loss carryover is from recording an impairment charge that occurred in 2009, it can be carried forward one year and must be offset by a capital gain. The Company has determined that is more likely than not that the remaining deferred tax assets will be realized and that an additional valuation allowance for such assets is not currently required. The Company accounts for its uncertain tax positions under the provision of FASB ASC 740, Income Taxes. At December 31, 2013 and 2012, the Company had no reserves for uncertain tax positions. Revenue Recognition – The Company recognizes revenue on sales of products when title passes which can occur at the time of shipment or when the goods arrive at the customer location depending on the agreement with the customer. The Company sells its products to both distributors and end-users. Sales to distributors and end-users are recorded based upon the criteria governed by the sales, delivery, and payment terms stated on the invoices from the Company to the purchaser. In addition to transfer of title / risk of loss, all revenue is recorded in accordance with the criteria outlined within SAB 104 and FASB ASC 605 Revenue Recognition: a.) persuasive evidence of an arrangement (principally in the form of customer sales orders and the Company’s sales invoices) b.) delivery and performance (evidenced by proof of delivery, e.g. the shipment of film and substrates with bill of lading used for proof of delivery for FOB shipping point terms, and the carrier booking confirmation report used for FOB destination terms). Once the finished product is shipped and physically delivered under the terms of the invoice and sales order, the Company has no additional performance or service obligations to complete c.) a fixed and determinable sales price (the Company’s pricing is established and is not based on variable terms, as evidenced in either the Company’s invoices or the limited number of distribution agreements; the Company rarely grants extended payment terms and has no history of concessions) d.) a reasonable likelihood of payment (the Company’s terms are standard, and the Company does not have a substantial history of customer defaults or non- payment) Sales are reported on a net basis by deducting credits, estimated normal returns and discounts. The Company’s return policy does not vary by geography. The customer has no rotation or price protection rights and the Company is not under a warranty obligation. Freight billed to customers is included in sales. Shipping costs are included in cost of goods sold. reSuLtS of operationS YEAR ENDED DECEMBER 31, 2013 COMPARED TO YEAR ENDED DECEMBER 31, 2012 Sales – The Company’s net sales increased 1.0% in 2013 to a record $17.5 million compared to net sales of $17.3 million in 2012. Domestic realized a 2.0% sales increase as sales grew from $7.1 million in 2012 to $7.3 million in 2013, as both chemical and emulsion sales were stronger in 2013 due to improved distribution in the central region of the United States. Improved film distribution in Asia also resulted in a 2.1% increase in Export sales versus 2012. IKONICS Imaging realized a 3.4% sale increase in 2013 as equipment sales improved. The equipment sales increase is partially related to the introduction of new equipment. 6 Partially offsetting these increases was a 29.8% decrease in Micro-Machining mask sales related to the loss of a large customer. The 13.4% DTX sales decrease is related to the 2012 sale of a DTX printer. There was no sale of a DTX printer in 2013 and the Company anticipates that most future DTX printer sales will be made directly by its strategic printer manufacturing partner and not the Company. Gross Profit – Gross profit in 2013 was $6.9 million, or 39.7% of sales, compared to $6.9 million, or 40.1% of sales in 2012. Gross margins were unfavorably impacted by an increase in Micro-Machining production costs related to the Company’s efforts to improve its production capacity and capabilities and a decrease in sales volume as a large portion of Micro-Machining production costs are fixed, dropping Micro-Machining gross margins from 5.3% in 2012 to negative 54.5% in 2013. IKONICS Imaging gross margins decreased from 54.0% in 2012 to 52.3% in 2013 as higher margin mask sales decreased while lower margin equipment sales increased. These gross margin decreases were offset by an increase in DTX gross margins from 74.8% in 2012 to 82.7% in 2013 and an increase in Export gross margins from 26.8% in 2012 to 28.1% in 2013 as both divisions realized a more favorable sales mix. Increased volumes helped to improve Domestic margins to 44.1% in 2013 from 43.3% in 2012. Selling, General and Administrative Expenses – Selling, general and administrative expenses were $5.4 million, or 30.7% of sales, in 2013 compared to $5.3 million, or 30.5% of sales, in 2012. The increase in selling, general and administrative expenses reflects increased personnel and travel costs for Micro- Machining related to improving, implementing and promoting its new technologies and higher selling and promotional expenses for Domestic to support sales initiatives in the Domestic screen markets. These increases have been partially offset by a decrease in IKONICS Imaging selling expenses resulting from lower staffing levels. Research and Development Expenses – Research and development expenses in 2013 were $649,000, or 3.7% of sales, versus $630,000, or 3.6% of sales, in 2012. The cost increase is related to higher personnel and supply expenses. Research and development expense in 2012 was impacted by a $23,000 abandonment of patent applications. The Company records patent application costs as an asset and amortizes those costs upon successful completion of the application process or expenses those costs when an application is abandoned. There were no expenses related to the abandonment of patent application costs in 2013. Interest Income – The Company earned $7,000 of interest income in 2013 compared to $12,000 in 2012. The interest earned in 2013 and 2012 is related to interest received from the Company’s short-term investments, which consist of fully insured certificates of deposit with original maturities ranging from 6 to 12 months. Income Taxes – During 2013, the Company realized income tax expense of $245,000, or an effective rate of 26.4%, compared to income tax expense of $351,000, or an effective rate of 33.6%, for the same period in 2012. The Company’s income tax expense and effective rate in 2013 was favorably impacted by 2012 tax law changes related to research and development credits. Since the tax law changes reinstating the credit were enacted in the first quarter of 2013, the resulting tax benefit was not allowed to be included in the Company’s 2012 tax provision under Generally Accepted Accounting Principles. Accordingly, the benefit was recognized in 2013. The income tax provision for the 2013 and 2012 periods also differs from the expected tax expense due to the benefits of the domestic manufacturing deduction, 2013 credits for research and development and other non-deductible items. IKONICS CORPORATION | 2013 ANNUAL REPORTLiquidity and capitaL reSourceS The Company has financed its operations principally with funds generated from operations. These funds have been sufficient to cover the Company’s normal operating expenditures, annual capital requirements, research and development expenditures, and a one-time dividend distribution in 2012. Cash and cash equivalents were $1,704,000 and $968,000 at December 31, 2013 and 2012, respectively. In addition to its cash, the Company also held $1,465,000 of short term investments as of December 31, 2013 and $1,443,000 of short-term investments as of December 31, 2012. The Company generated $1,467,000 in cash from operating activities during 2013, compared to generating $1,182,000 of cash from operating activities in 2012. Cash provided by operating activities is primarily the result of the net income adjusted for non cash depreciation and amortization, deferred taxes, and certain changes in working capital components discussed in the following paragraph. During 2013, inventories decreased by $124,000. Lower raw material levels are related to the timing of purchases and efforts to tighten inventory volumes. The $21,000 decrease in prepaid expenses and other assets is related to timing of insurance payments while trade receivables decreased by $9,000. Accounts payable decreased $62,000 due to the timing of payments to and purchases from vendors while accrued liabilities decreased $5,000. Income taxes payable decreased $62,000 and income tax receivable increased $16,000 due to the timing of estimated 2013 tax payments compared to the calculated 2013 tax liability. During 2012, inventories increased by $444,000. In addition to increased finished goods levels, part of the inventory increase is related to increased raw material purchases to take advantage of volume discounts and to protect against future price increases. The trade receivables decrease of $121,000 is related to improved collections. The $42,000 increase in prepaid expenses and other assets is related to the purchases of equipment utilized for sales promotion. Accounts payable increased $44,000 due to the timing of payments to and purchases from vendors while accrued liabilities increased $58,000 due to the timing of the Company’s payroll and customer prepayments. Income taxes payable increased $84,000 and the Company’s income tax receivable decreased $59,000 due to timing of estimated 2012 tax payments compared to the calculated 2012 tax liability. During 2013, investing activities used $820,000. Purchases of property and equipment were $763,000. The majority of these purchases were made to improve Micro-Machining capabilities. Equipment purchases were also made to upgrade research and development equipment and facilities, including improvements to both DTX equipment and equipment and facilities related to screen printing and IKONICS Imaging. The Company realized $36,000 in proceeds from the sale of two vehicles. Also in 2013, the Company incurred $71,000 in patent application costs that the Company records as an asset and amortizes upon successful completion of the application process. The Company also invested $1,815,000 in twelve fully insured certificates of deposit during 2013. Twelve certificates of deposit totaling $1,793,000 matured during 2013. During 2012, investing activities used $172,000. Purchases of property and equipment were $567,000, mainly for manufacturing equipment, mandatory elevator upgrades and three vehicles. The Company realized $59,000 in proceeds from the sale of three vehicles and on a like-kind equipment exchange. Also in 2012, the Company incurred $57,000 in patent application costs that the Company records as an asset and amortizes upon successful completion of the application process. The Company also invested $1,858,000 in nine fully insured certificates of deposit during 2012. Eleven certificates of deposit totaling $2,250,000 matured during 2012. In 2013 and 2012, the Company received $89,000 from financing activities from the issuance of 13,695 and 13,888 shares, respectively, of common stock from the exercise of stock options. In 2012, the Company also declared and paid a one-time special cash dividend of $1.00 per share. The total dividend paid was $1,998,000. A bank line of credit exists providing for borrowings of up to $1,250,000 through May 31, 2015. The Company expects to obtain a similar line of credit when the current line of credit expires. The line of credit is collateralized by trade receivables and inventories and bears interest at 2.5 percentage points over the 30 day LIBOR rate. The Company did not utilize this line of credit during 2013 and 2012 and there were no borrowings outstanding as of December 31, 2013 and 2012. There are no financial covenants related to the line of credit. The Company believes that current financial resources, its line of credit, cash generated from operations and the Company’s capacity for debt and/or equity financing will be sufficient to fund current and anticipated business operations. The Company also believes that its low debt levels and available line of credit make it unlikely that a decrease in demand for the Company’s products would impair the Company’s ability to fund operations. capitaL expenditureS During 2013, the Company had $763,000 of capital expenditures. The majority of these purchases were made to improve Micro-Machining capabilities. Equipment purchases were also made to upgrade research and development equipment and facilities, including improvements to both DTX equipment and equipment and facilities related to screen printing and IKONICS Imaging in addition to a vehicle for sales personnel. In 2012, the Company had $567,000 of capital expenditures. Capital expenditures in 2012 were mainly for manufacturing equipment upgrades to increase capacity and improve product quality. The Company also incurred expenditures related to mandatory elevator upgrades and the purchase of three vehicles. The Company expects capital expenditures in 2014 of approximately $600,000. The planned expenditures primarily will be for mandatory elevator upgrades, manufacturing equipment necessary for anticipated Micro-Machining aerospace business, other manufacturing equipment upgrades and vehicles for sale personnel. These commitments are expected to be funded with cash generated from operating activities. internationaL activity The Company markets its products in numerous countries in all regions of the world, including North America, Europe, Latin America, and Asia. The Company’s 2013 foreign sales of $5,642,000 were approximately 32.3% of total sales, compared to the 2012 foreign sales of $5,523,000, which were 31.9% of total sales. The foreign sales increase in 2013 was primarily due to an increase in Asian sales from improved distribution. The Company’s foreign transactions are primarily negotiated, invoiced and paid in U.S. dollars, while a portion is transacted in Euros. IKONICS has not implemented an economic hedging strategy to reduce the risk of foreign currency translation exposures, which management does not believe to be significant based on the scope and geographic diversity of the Company’s foreign operations as of December 31, 2013. Furthermore, the impact of foreign exchange on the Company’s balance sheet and operating results was not material in either 2013 or 2012. 7 7 future outLook Fiscal Year Ended December 31, 2013: IKONICS has spent on average approximately 4% of its sales dollars for the past few years in research and development and has made capital expenditures related to its DTX and Micro-Machining programs. The Company plans to maintain its efforts in this area to expedite internal product development as well as to form technological alliances with outside experts to commercialize new product opportunities. First Quarter Second Quarter Third Quarter Fourth Quarter High $ 13.74 17.99 18.98 19.45 Low $ 7.92 12.00 16.06 14.25 $ 9.10 $ 7.03 9.35 9.45 9.39 7.54 7.70 7.75 Fiscal Year Ended December 31, 2012: First Quarter Second Quarter Third Quarter Fourth Quarter As of February 23, 2014, the Company had approximately 596 shareholders. Declaration and payment of dividends is within the sole discretion of the Company’s board of directors. During the fourth quarter of 2012, the Company declared a one-time special cash dividend of $1.00 per share, paid on December 31, 2012, amounting to $1,998,475. This was the first and only cash dividend paid in the Company’s history. management’S report The financial statements of IKONICS Corporation have been prepared by Company management who are responsible for their content. These statements have been prepared in accordance with accounting principles generally accepted in the United States of America and, where appropriate, reflect estimates based on judgements of management. The financial statements have been audited by McGladrey LLP, an indepen dent registered public accounting firm. The Audit Committee of the Board of Directors, comprised of outside directors, meets periodically with the independent auditors and management to discuss the company’s internal accounting controls and financial reporting matters. Our independent regis tered public accounting firm has unrestricted access to the Audit Committee, without management present, to discuss the results of their audit, the adequacy of internal accounting controls, and the quality of financial reports. WILLIAM C. ULLAND JON GERLACH Chairman, President & CEO Chief Financial Officer & V.P. Finance The Company continues to make progress on its new Micro-Machining business initiative. The Company has entered into agreements with several major aerospace companies to determine the feasibility of using its unique technologies in the production of military and commercial aircraft. The Company is currently supplying products to the aerospace industry for use in the construction of new generation commercial aircraft. Although sequestration of the Department of Defense budget and delays in the launching of new commercial aircraft fleets could adversely affect some of these sales, progress is being made on a number of in-house feasibility projects, and the Company believes that several of these could lead to ongoing business. In anticipation of this business, the Company is expanding its Micro- Machining capacity and patent applications. The Company is also continuing to make progress on its DTX business initiatives. In addition to its growing inkjet technology business, the Company offers a range of products for creating texture surfaces and has introduced a fluid for use in prototyping. The Company is currently working with its DTX customers on training, production optimization, and product improvements. The Company has been awarded European, Japanese and United States patents on its DTX technologies. The Company has modified its DTX technology to enter the market for prototyping and 3D printing. Domestically, both the Domestic Chromaline Screen Print Product and its IKONICS Imaging units remain profitable mature markets and require aggressive strategies to grow market share. Although there will be challenges, the Company believes these businesses will continue to grow and prosper. In addition to its traditional emphasis on domestic markets, the Company will continue efforts to grow its business internationally by attempting to develop new markets and expanding market share where it has already established a presence. Other future activities undertaken to expand the Company’s business may include acquisitions, building improvements, equipment additions, new product development and marketing opportunities. off-baLance Sheet arrangementS The Company has no off-balance sheet arrangements except for a one-year storage lease at $1,500 per month. recent accounting pronouncementS None market for common equity and reLated StockhoLder matterS The Company’s Common Stock is traded on the Nasdaq Capital Market under the symbol IKNX. The following table sets forth, for the fiscal quarters indicated, the high and low sales prices for the Company’s Common Stock as reported on the Nasdaq Capital Market for the periods indicated. 8 IKONICS CORPORATION | 2013 ANNUAL REPORTmanagement’S annuaL report on internaL controL over financiaL reporting Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f ) under the Exchange Act. Our internal control system is designed to provide reasonable assurance to our management and board of directors regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that: • Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; • Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and • Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements. Management assessed the effectiveness of our internal control over financial reporting as of December 31, 2013. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control – Integrated Framework. Based on management’s assessment and those criteria, management believes that, as of December 31, 2013, the Company maintained effective internal control over financial reporting. This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Our management’s report of the effectiveness on the design and operation of our internal control over financial reporting was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this annual report. WILLIAM C. ULLAND JON GERLACH Chairman, President & CEO Chief Financial Officer & V.P. Finance report of independent regiStered pubLic accounting firm TO THE BOARD OF DIRECTORS AND STOCKHOLDERS IKONICS CORPORATION We have audited the accompanying balance sheets of IKONICS Corporation as of December 31, 2013 and 2012, and the related statements of income, stockholders’ equity, and cash flows for the years then ended. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of IKONICS Corporation as of December 31, 2013 and 2012, and the results of its operations and its cash flows for the years then ended, in conformity with U.S. generally accepted accounting principles. /s/ McGladrey LLP Minneapolis, Minnesota March 5, 2014 9 9 baLance SheetS DECEMBER 31, 2013 AND 2012 aSSetS CURRENT ASSETS: 2013 2012 Cash and cash equivalents (Note 7) .............................................................................................................. $ 1,704,300 $ Short-term investments ............................................................................................................................... Trade receivables, less allowance of $62,000 in 2013 and $43,000 in 2012 (Notes 5, 7, and 8) ....................... Inventories (Note 8) ..................................................................................................................................... Prepaid expenses and other assets .............................................................................................................. Income tax receivable ................................................................................................................................. Deferred income taxes (Note 2) .................................................................................................................... Total current assets .................................................................................................................................... PROPERTY, PLANT, AND EQUIPMENT, AT COST: Land and building ....................................................................................................................................... Machinery and equipment ........................................................................................................................... Office equipment ........................................................................................................................................ Vehicles ..................................................................................................................................................... Less accumulated depreciation .................................................................................................................... 1,464,878 2,050,853 2,554,942 103,687 16,400 150,000 8,045,060 6,123,890 3,781,282 722,567 237,194 10,864,933 5,230,837 5,634,096 INTANGIBLE ASSETS, less accumulated amortization of $535,421 in 2013 and $482,107 in 2012 (Note 3) ..................... 322,647 $ 14,001,803 $ 967,943 1,442,939 2,060,312 2,678,864 124,983 - 142,000 7,417,041 6,063,965 3,219,598 700,062 237,488 10,221,113 4,759,235 5,461,878 305,357 13,184,276 LiabiLitieS and StockhoLderS’ equity CURRENT LIABILITIES: 2013 2012 Accounts payable ....................................................................................................................................... $ 532,294 $ Accrued compensation ................................................................................................................................ Other accrued liabilities ............................................................................................................................... Income taxes payable .................................................................................................................................. Total current liabilities ................................................................................................................................. DEFERRED INCOME TAXES (Note 2) .................................................................................................................... Total liabilities ............................................................................................................................................ 274,936 67,755 - 874,985 527,000 1,401,985 593,922 265,822 81,635 82,152 1,023,531 366,000 1,389,531 STOCKHOLDERS’ EQUITY: Preferred stock, par value $.10 per share; authorized 250,000 shares: issued none - - Common stock, par value $.10 per share; authorized 4,750,000 shares: issued and outstanding 2,012,170 shares in 2013 and 1,998,475 shares in 2012 (Note 6) Additional paid-in capital ............................................................................................................................. Retained earnings ....................................................................................................................................... Total stockholders’ equity ............................................................................................................................ 201,217 2,592,038 9,806,563 12,599,818 $ 14,001,803 $ 199,848 2,470,507 9,124,390 11,794,745 13,184,276 See notes to financial statements. 10 IKONICS CORPORATION | 2013 ANNUAL REPORT StatementS of income YEARS ENDED DECEMBER 31, 2013 AND 2012 NET SALES ............................................................................................................................................... $ 17,491,408 $ 17,312,407 COST OF GOODS SOLD ............................................................................................................................... 10,553,553 10,367,563 2013 2012 GROSS PROFIT .......................................................................................................................................... SELLING, GENERAL AND ADMINISTRATIVE EXPENSES ...................................................................................... RESEARCH AND DEVELOPMENT EXPENSES .................................................................................................... INCOME FROM OPERATIONS ........................................................................................................................ INTEREST INCOME ..................................................................................................................................... INCOME BEFORE INCOME TAXES .................................................................................................................. FEDERAL AND STATE INCOME TAXES (NOTE 2) ............................................................................................... NET INCOME ............................................................................................................................................. $ EARNINGS PER COMMON SHARE: 6,937,855 5,368,400 649,325 6,017,725 920,130 7,043 927,173 245,000 682,173 Basic ...................................................................................................................................................................... Diluted .................................................................................................................................................................... $ $ 0.34 0.34 WEIGHTED AVERAGE COMMON SHARES: 6,944,844 5,282,187 629,776 5,911,963 1,032,881 12,050 1,044,931 351,000 693,931 0.35 0.35 $ $ $ Basic ...................................................................................................................................................................... Diluted .................................................................................................................................................................... 2,006,843 2,010,659 1,988,066 1,990,847 See notes to financial statements. StatementS of StockhoLderS’ equity YEARS ENDED DECEMBER 31, 2013 AND 2012 Balance At December 31, 2011 1,984,587 $ 198,459 $ 2,363,150 $ 10,428,934 $ 12,990,543 Common Shares Stock Amount Additional Paid-In Capital Retained Earnings Total Stockholders’ Equity Net income Exercise of stock options Cash dividend paid Tax benefit resulting from stock option exercises Stock based compensation and related tax benefit Balance At December 31, 2012 Net income Exercise of stock options Tax benefit resulting from stock option exercises Stock based compensation and related tax benefit Balance At December 31, 2013 See notes to financial statements. - 13,888 - - - 1,998,475 - 13,695 - - - 1,389 - - - 1,900 17,818 199,848 2,470,507 - 1,369 - - - 88,029 19,595 13,907 - 87,639 693,931 - 693,931 89,028 - (1,998,475) (1,998,475) - - 9,124,390 682,173 - - - 1,900 17,818 11,794,745 682,173 89,398 19,595 13,907 2,012,170 $ 201,217 $ 2,592,038 $ 9,806,563 $ 12,599,818 11 11 StatementS of caSh fLowS YEARS ENDED DECEMBER 31, 2013 AND 2012 CASH FLOW FROM OPERATING ACTIVITIES: 2013 2012 Net Income .................................................................................................................................................... $ 682,173 $ 693,931 ADJUSTMENTS TO RECONCILE NET INCOME TO NET CASH PROVIDED BY OPERATING ACTIVITIES: Depreciation ................................................................................................................................................... Amortization ................................................................................................................................................... Stock based compensation .............................................................................................................................. Net gain on sale of vehicles and equipment exchange ........................................................................................ Loss on intangible asset abandonment ............................................................................................................. Deferred income taxes .................................................................................................................................... CHANGES IN WORKING CAPITAL COMPONENTS: Trade receivables ............................................................................................................................................ Inventories ..................................................................................................................................................... Prepaid expenses and other assets .................................................................................................................. Income tax refund receivable ........................................................................................................................... Accounts payable ........................................................................................................................................... Accrued liabilities ........................................................................................................................................... Income taxes payable ...................................................................................................................................... 568,791 53,314 13,907 (13,979) - 153,000 9,459 123,922 21,296 (16,400) (61,628) (4,766) (62,557) 489,206 54,653 17,818 (7,163) 23,122 30,000 120,635 (444,030) (42,060) 59,322 44,390 58,074 84,052 Net cash provided by operating activities ...................................................................................................... 1,466,532 1,181,950 CASH FLOWS FROM INVESTING ACTIVITIES: Purchases of property and equipment ............................................................................................................... Proceeds from sale of equipment and vehicles .................................................................................................. Purchases of intangibles ................................................................................................................................. Purchases of short-term investments ............................................................................................................... Proceeds from sale of short-term investments ................................................................................................... Net cash used in investing activities ............................................................................................................. (762,537) 35,507 (70,604) (1,814,878) 1,792,939 (819,573) (566,519) 59,500 (56,770) (1,857,990) 2,250,054 (171,725) CASH FLOWS FROM FINANCING ACTIVITIES: Cash dividend paid ......................................................................................................................................... Proceeds from exercise of stock options ........................................................................................................... Net cash provided by (used in) financing activities ......................................................................................... - 89,398 89,398 (1,998,475) 89,028 (1,909,447) NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS ................................................................................... 736,357 (899,222) CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR ............................................................................................. 967,943 1,867,165 CASH AND CASH EQUIVALENTS AT END OF YEAR ...................................................................................................... $ 1,704,300 SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Cash paid for income taxes, net of refunds received of $13,026 and $61,650, respectively .................................. $ 171,139 $ $ 967,943 177,626 See notes to financial statements 12 IKONICS CORPORATION | 2013 ANNUAL REPORT noteS to financiaL StatementS YEARS ENDED DECEMBER 31, 2013 AND 2012 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Inventories - Inventories are stated at the lower of cost or market using the last-in, first-out (LIFO) method. If the first-in, first-out (FIFO) cost method had been used, inventories would have been approximately $1,248,000 and $1,246,000 higher than reported at December 31, 2013 and 2012, respectively. The major components of inventories are as follows: Description of Business and Foreign Export Sales - IKONICS Corporation (the Company) develops and manufactures high-quality photochemical imaging systems for sale primarily to a wide range of printers and decorators of surfaces. Customers’ applications are primarily screen printing and abrasive etching. The Company’s principal markets are throughout the United States. In addition, the Company sells to Europe, Latin America, Asia, and other parts of the world. The Company extends credit to its customers, all on an unsecured basis, on terms that it establishes for individual customers. Raw Materials Work-in-progress Finished goods Reduction to LIFO cost Total Inventories 2013 2012 $ 1,952,398 $ 2,072,540 389,501 1,461,264 373,512 1,478,444 (1,248,221) (1,245,632) $ 2,554,942 $ 2,678,864 Foreign export sales approximated 32.3% of net sales in 2013 and 31.9% of net sales in 2012. The Company’s trade receivables at December 31, 2013 and 2012 due from foreign customers were 32.5% and 34.4% of total trade receivables, respectively. The foreign export receivables are composed primarily of open credit arrangements with terms ranging from 30 to 90 days. No single customer or foreign country represented greater than 10% of net sales in 2013 or in 2012. The Company considers events or transactions that occur after the balance sheet date but before the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. Subsequent events have been evaluated through March 5, 2014, the date the financial statements were issued. A summary of the Company’s significant accounting policies follows: Cash Equivalents - The Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. Cash equivalents consist of money market funds in which the carrying value approximates market value because of the short maturity of these instruments. The money market fund utilized by IKONICS invests in United States dollar denominated securities that present minimal credit risk and consist of investments in debt securities issued or guaranteed by the United States government or by United States government agencies or instrumentalities and repurchase agreements fully collateralized by the United States Treasury and United States government securities. Short-Term Investments - Short-term investments consist of fully insured certificates of deposit with original maturities ranging from six to twelve months as of December 31, 2013 and 2012, respectively. Trade Receivables - Trade receivables are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on an on-going basis. Management determines the allowance for doubtful accounts by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history, and current economic conditions. Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when received. Accounts are considered past due if payment is not received according to agreed-upon terms. A small percentage of the trade receivables balance is denominated in a foreign currency with no concentration in any given country. At the end of each reporting period, the Company analyzes the receivable balance for customers paying in a foreign currency. These balances are adjusted to each quarter or year end spot rate in accordance with FASB ASC 830, Foreign Currency Matters. Foreign currency transactions and translation adjustments did not have a significant effect on the Balance Sheet or the Statements of Income, Stockholders’ Equity and Cash Flows for 2013 and 2012. Depreciation - Depreciation of property, plant and equipment is computed using the straight-line method over the following estimated useful lives: Buildings ............................................ Machinery and equipment ................... Office equipment ................................ Vehicles ............................................. Years 15-40 5-10 3-10 3 Intangible Assets – Intangible assets consist of patents, licenses and covenants not to compete arising from business combinations. Intangible assets are amortized on a straight-line basis over their estimated useful lives or agreement terms. Intangible assets with indefinite lives are assessed for impairment whenever events or circumstances indicate the carrying value may not be fully recoverable by comparing the carrying value of the intangibles to their future undiscounted cash flows. To the extent the undiscounted cash flows are less than the carrying value, analysis is performed based on several criteria, including, but not limited to, revenue trends, discounted operating cash flows and other operating factors to determine the impairment amount. As of December 31, 2013, the remaining estimated weighted average useful lives of intangible assets are as follows: Patents .............................................. Licenses ............................................ Non-compete agreements ................... Years 14.3 3.4 1.5 Fair Value of Financial Instruments – The carrying amounts of financial instruments, including cash and cash equivalents, short-term investments, trade receivables, accounts payable, and accrued liabilities approximate fair value due to the short maturities of these instruments. Revenue Recognition - The Company recognizes revenue on sales of products when title passes which can occur at the time of shipment or when the goods arrive at the customer location depending on the agreement with the customer. The Company sells its products to both distributors and end-users. Sales to distributors and end-users are recorded based upon the criteria governed by the sales, delivery, and payment terms stated on the invoices from the Company to the purchaser. In addition to transfer of title / risk of loss, all revenue is recorded in accordance with the criteria outlined within SAB 104 and FASB ASC 605 Revenue Recognition: (a) persuasive evidence of an arrangement (principally in the form of customer sales orders and the Company’s sales invoices, as generally there is no other formal agreement underlying the sale transactions) 13 13 (b) delivery and performance (evidenced by proof of delivery, e.g. the shipment of film and substrates with bill of lading used for proof of delivery for FOB shipping point terms, and the carrier booking confirmation report used for FOB destination terms. Once the finished product is shipped and physically delivered under the terms of the invoice and sales order, the Company has no additional performance or service obligations to complete) Earnings per Common Share (EPS) - Basic EPS is calculated using net income divided by the weighted average of common shares outstanding. Diluted EPS is similar to Basic EPS except that the weighted average number of common shares outstanding is increased to include the number of additional common shares, when dilutive, that would have been outstanding if the potential dilutive common shares, such as those shares subject to options, had been issued. (c) a fixed and determinable sales price (the Company’s pricing is established and is not based on variable terms, as evidenced in either the Company’s invoices or the limited number of distribution agreements; the Company rarely grants extended payment terms and has no history of concessions) (d) a reasonable likelihood of payment (the Company’s terms are standard, and the Company does not have a substantial history of customer defaults or non-payment) Sales are reported on a net basis by deducting credits, estimated normal returns and discounts. The Company’s return policy does not vary by geography. The customer has no rotation or price protection rights and the Company is not under a warranty obligation. Freight billed to customers is included in sales. Shipping costs are included in cost of goods sold. Self-Funded Medical Insurance - Beginning in January 2012, the Company moved from a fully insured to a self-funded medical insurance plan. The Company contracted with an administrative service company or a “third party administrator” to supervise and administer the program and act as the Company’s fiduciary and representative. The Company has reduced its risk under this self-funded plan by purchasing both specific and aggregate stop-loss insurance coverage for individual claims and total annual claims in excess of prescribed limits. The Company records estimates for claim liabilities based on information provided by the third-party administrators, historical claims experience, the life cycle of claims, expected costs of claims incurred but not paid, and expected costs to settle unpaid claims. The Company regularly monitors its estimated insurance-related liabilities. Actual claims experience may differ from the Company’s estimates. Costs related to the administration of the plan and related claims are expensed as incurred. The total liability for self-funded medical insurance was $55,000 as of December 31, 2013 and $54,000 as of December 31, 2012. The liability related to self-funded medical insurance is included within other accrued liabilities in the balance sheet. Deferred Taxes - Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company follows the accounting standard on accounting for uncertainty in income taxes, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under this guidance, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement. The guidance on accounting for uncertainty in income taxes also addresses derecognition, classification, interest and penalties on income taxes, and accounting in interim periods. Shares used in the calculation of diluted EPS are summarized below: 2013 2012 Weighted average common shares out- standing ............................................... 2,006,843 1,988,066 Dilutive effect of stock options ................ 3,816 2,781 Weighted average common and common equivalent shares outstanding ................ 2,010,659 1,990,847 There were no anti-dilutive options at December 31, 2013 and 2012. Employee Stock Plan - The Company accounts for employee stock options under the provision of ASC 718 Compensation – Stock Compensation. Use of Estimates - The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the allowance for doubtful trade receivables, the reserve for inventory obsolescence, self-funded health insurance, and the valuation allowance for deferred tax assets. 2. INCOME TAXES Income tax expense for the years ended December 31, 2013 and 2012 consists of the following: 2013 2012 Current: Federal .................................................. $ 91,000 $ 319,000 State ..................................................... Deferred ............................................... 1,000 92,000 153,000 2,000 321,000 30,000 $ 245,000 $ 351,000 The expected provision for income taxes, computed by applying the U.S. federal income tax rate of 34% in 2013 and 35% in 2012 to income before taxes, is recon- ciled to income tax expense as follows: 2013 2012 Expected provision for federal income taxes . $ 315,000 $ 365,700 State income taxes, net of federal benefit .... Domestic manufacturers deduction ............. Non-deductible meals, entertainment, and life insurance .................................................. Prior year adjustments................................ Research and development credit ............... Other ........................................................ 16,000 (20,000) 13,000 (32,000) (45,000) (2,000) (400) (31,800) 20,800 - - (3,300) $ 245,000 $ 351,000 14 IKONICS CORPORATION | 2013 ANNUAL REPORT Net deferred tax liabilities consist of the following as of December 31, 2013 and 2012: The deferred tax amounts described to the left have been included in the accompanying balance sheet as of December 31, 2013 and 2012 as follows: Deferred tax assets: Accrued vacation ....................................... $ 23,000 $ 25,000 2013 2012 Inventories ................................................. Allowance for doubtful accounts ................. Allowance for sales returns ......................... Capital loss carryforward ............................ Research and development credit carryforward Less valuation allowance ............................ Deferred tax liabilities: 105,000 9,000 13,000 309,000 17,000 (326,000) 150,000 101,000 5,000 11,000 323,000 - (323,000) 142,000 Current Assets Noncurrent liabilities 2013 2012 $ $ 150,000 $ 142,000 (527,000) (366,000) (377,000) $ (244,000) At December 31, 2013 and 2012, the Company recorded a valuation allowance of $326,000 and $323,000, respectively, related to Minnesota research and development credit and U.S. Federal capital loss carryovers as the company believes it is more likely than not that the deferred tax assets will not be realized. As of December 31, 2013, the capital loss can be carried forward one year and must be offset by a capital gain. Property and equipment and other assets .... Intangible assets ........................................ (468,000) (59,000) (324,000) (42,000) Net deferred tax liabilities ........................... $ (377,000) $ (224,000) It has been the Company’s policy to recognize interest and penalties related to uncertain tax positions in income tax expense. As of December 31, 2013 and 2012, there was no liability for unrecognized tax benefits. The Company is subject to federal and state taxation. The material jurisdictions that are subject to examination by tax authorities primarily include Minnesota and the United States, for tax years 2010, 2011, 2012 and 2013. 3. INTANGIBLE ASSETS Intangible assets consist of patents, patent applications, licenses and covenants not to compete arising from business combinations. Capitalized patent application costs are included with patents. Intangible assets are amortized on a straight-line basis over their estimated useful lives or terms of their agreement, whichever is shorter. The Company wrote off costs related to patent applications of $23,000 in 2012. No other impairment adjustments to intangible assets were made during the years ended December 31, 2013 or 2012. Intangible assets at December 31, 2013 and 2012 consist of the following: December 31, 2013 December 31, 2012 Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Amortized intangible assets: Patents ..................................................................... $ 455,068 $ (155,970) $ 384,464 $ (141,447) Licenses ................................................................... Non-compete agreements .......................................... 100,000 303,000 (86,459) (292,992) 100,000 303,000 (83,334) (257,326) $ 858,068 $ (535,421) $ 787,464 $ (482,107) Aggregate amortization expense: For the years ended December 31 2013 2012 Estimated amortization expense for the years ending December 31: $53,314 $54,653 2014 .................................................. $25,000 2015 .................................................. 2016 .................................................. 2017 .................................................. 2018 .................................................. 23,000 20,000 20,000 18,000 In connection with the license agreements, the Company has agreed to pay royalties ranging from 3% to 5% on the sales of products subject to the agreements. The Company incurred $19,000 of expense under these agreements during 2013, and $87,000 during 2012 which have been included in selling, general and administrative expenses in the Statements of Income. 15 15 4. RETIREMENT PLAN The Company has established a salary deferral plan under Section 401(k) of the Internal Revenue Code. Such deferrals accumulate on a tax-deferred basis until the employee withdraws the funds. The Company contributes up to 5% of each eligible employee’s compensation. Total retirement expense for the years ended December 31, 2013 and 2012 was approximately $208,000 and $204,000, respectively. 5. SEGMENT INFORMATION The Company’s reportable segments are strategic business units that offer different products and have varied customer bases. There are five reportable segments: Domestic, Export, IKONICS Imaging, Digital Texturing (DTX) and Micro-Machining. Domestic sells screen printing film, emulsions, and inkjet receptive film to distributors located in the United States and Canada. IKONICS Imaging sells photo resistant film, art supplies, glass, metal medium and related abrasive etching equipment to end user customers located in the United States and Canada. Micro-Machining provides sound deadening technology to the aerospace industry along with products and services for etched composites, ceramics, glass and silicon wafers. DTX includes products and customers related to patented and proprietary inkjet technology used for mold texturing. Export sells primarily the same products as Domestic and the IKONICS Imaging products not related to Micro-Machining or DTX. In previous periods, the segment designated as Other included both Micro-Machining and DTX. Beginning in 2013, the Company began to report DTX and Micro-Machining as separate segments. The accounting policies of the segments are the same as those described in the summary of significant accounting policies included in Note 1. Management evaluates the performance of each segment based on the components of divisional income, and does not allocate assets and liabilities to segments except for trade receivables. Financial information with respect to the reportable segments follows: For the year ended December 31, 2013: Domestic Export IKONICS Imaging DTX Micro- Machining Net sales .................................................. $ 7,260,934 $ 5,641,544 $ 3,836,762 $ 407,193 $ 344,975 $ Cost of goods sold ..................................... 4,062,141 4,057,111 1,831,047 Gross profit (loss) ...................................... 3,198,793 1,584,433 2,005,715 Selling, general and administrative*............. 1,307,154 578,084 977,574 Research and development* ....................... - - - 70,343 336,850 474,782 - 532,911 (187,936) 446,803 - Unallocated* Total - - - 1,584,003 649,325 $ 17,491,408 10,553,553 6,937,855 5,368,400 649,325 Income (loss) from operations ..................... $ 1,891,639 $ 1,006,349 $ 1,028,141 $ (137,932) (634,739) $ (2,233,328) $ 920,130 For the year ended December 31, 2012: Domestic Export IKONICS Imaging DTX Micro- Machining Net sales .................................................. $ 7,118,912 $ 5,523,177 $ 3,708,987 $ 470,205 $ 491,126 $ Cost of goods sold ..................................... 4,036,339 4,042,689 1,705,054 Gross profit ............................................... 3,082,573 1,480,488 2,003,933 Selling, general and administrative*............. 1,226,107 607,453 1,099,812 Research and development* ....................... - - - 118,349 351,856 493,631 - 465,132 25,994 314,803 - Unallocated* Total - - - 1,540,381 629,776 $ 17,312,407 10,367,563 6,944,844 5,282,187 629,776 Income (loss) from operations ..................... $ 1,856,466 $ 873,035 $ 904,121 $ (141,775) (288,809) $ (2,170,157) $ 1,032,881 * The Company does not allocate all general and administrative expenses or any research and development expenses to its operating segments for internal reporting. Trade receivables by segment as of December 31, 2013 and December 31, 2012 were as follows: Dec 31, 2013 Dec 31, 2012 Domestic ....................................................... $ 1,012,057 $ 928,698 Export ............................................................ IKONICS Imaging ............................................ DTX ............................................................... Micro-Machining ............................................ Unallocated .................................................... 667,343 339,537 26,910 40,222 (35,216) 708,933 272,346 117,552 57,122 (24,339) Total .............................................................. $ 2,050,853 $ 2,060,312 16 IKONICS CORPORATION | 2013 ANNUAL REPORT6. STOCK OPTIONS The Company has a stock incentive plan for the issuance of up to 442,750 shares of common stock. The plan provides for granting eligible participants stock options or other stock awards, as described by the plan, at option prices ranging from 85% to 110% of fair market value at date of grant. Options granted expire up to seven years after the date of grant. Such options generally become exercisable over a three year period. A total of 115,573 shares of common stock are reserved for additional grants of options under the plan at December 31, 2013. Under the plan, the Company charged compensation cost of $13,907 and $17,818 against income in 2013 and 2012, respectively. As of December 31, 2013, there was approximately $20,000 of unrecognized compensation cost related to unvested share-based compensation awards granted which is expected to be recognized over the next three years. Proceeds from the exercise of stock options were $89,398 for 2013 and $89,028 for 2012. The fair value of options granted during 2013 and 2012 were estimated using the Black-Scholes option pricing model with the following assumptions: Dividend yield ........................................... 2013 0% Expected volatility ..................................... 43.9% Expected life of option ............................... Five years Risk-free interest rate ............................... Fair values of each option on grant date ..... 0.7% $4.72 2012 0% 41.8% Five years 0.8% $2.73 There were 4,250 options and 750 options granted during 2013 and 2012, respec- tively. FASB ASC 718, Compensation – Stock Compensation specifies that initial accruals be based on the estimated number of instruments for which the requisite service is expected to be rendered. Therefore, the Company is required to incorporate a preexisting forfeiture rate based on the historical forfeiture experience and prospective actuarial analysis, estimated at 3%. A summary of the status of the Company’s stock option plan as of December 31, 2013 and changes during the year then ended is presented below: Options Outstanding at January 1, 2013 Granted Exercised Expired and Forfeited Outstanding at December 31, 2013 Vested or expected to vest at December 31, 2013 Exercisable at December 31, 2013 Shares Weighted Average Exercise Price Contractual Term (years) Aggregate Intrinsic Value Weighted Average Remaining 21,362 4,250 (13,695) (500) 11,417 11,417 4,166 $ $ $ $ 6.72 12.56 6.53 12.56 8.87 8.87 6.57 2.67 2.67 1.24 $ $ $ 66,876 66,876 33,977 The weighted-average grant date fair value of options granted was $4.72 and $2.73 for the years ended December 31, 2013 and 2012, respectively. The total intrinsic value of options exercised was $95,477 for the year ended December 31, 2013 and $32,650 for the year ended December 31, 2012. The following table summarizes information about stock options outstanding at December 31, 2013: Range of Exercise Price Number Outstanding at Weighted-Average Remain- Weighted-Average Exercise Number Exercisable at Weighted-Average Exercise December 31, 2013 ing Contractual Life (years) Price December 31, 2013 Price Options Outstanding Options Exercisable $5.00-$5.99 $7.00-$7.99 $12.00-$13.00 1,500 6,167 3,750 11,417 0.31 2.24 4.31 2.67 $ $ $ $ 5.00 7.56 12.56 8.87 1,500 2,666 - 4,166 $ $ $ $ 5.00 7.45 - 6.57 17 17 7. CONCENTRATION OF CREDIT RISK The Company maintains its cash balances primarily in two financial institutions. As of December 31, 2013, the balance at each of the institutions exceeded the Federal Deposit Insurance Corporation coverage. Trade receivables are financial instruments that also expose the Company to concentration of credit risk. The large number of customers comprising the Company’s customer base and their dispersion across different geographic areas limits such exposure. In addition, the Company routinely assesses the financial strength of its customers and maintains an allowance for doubtful accounts that management believes will adequately provide for credit losses. 8. LINE OF CREDIT The Company has a $1,250,000 bank line of credit that provides for working capital financing. This line of credit is subject to renewal on May 31, 2015, is collateralized by trade receivables and inventories, and bears interest at 2.5 percentage points over 30-day LIBOR. There were no outstanding borrowings under this line of credit at December 31, 2013 and 2012. There are no financial covenants related to the line of credit. 9. NON-MONETARY TRANSACTION During 2012, the Company entered into a like-kind exchange with a customer where the Company and the Company’s customer exchanged digital texturing printers. In addition to the Company receiving a printer from the customer, the Company also received $35,000. A loss of $16,000 was recognized by the Company on the exchange. COMMON STOCK ADDITIONAL FINANCIAL INFORMATION Stockholders of record automatically receive quarterly earnings information, and street name holders may do so upon written request. For a copy of the Form 10-K, as filed with the Securities and Exchange Commission, and other financial information avail able at no charge to stockholders, please contact: JON GERLACH Chief Financial Officer IKONICS Corporation 4832 Grand Avenue, Duluth, MN 55807 Phone: (218) 628-2217 email: jgerlach@ikonics.com ANNUAL MEETING The Company’s annual meeting will be held: April 24, 2014 1:00 p.m. Kitchi Gammi Club 831 E. Superior Street Duluth, MN 55802 IKONICS Corporation common stock is traded on the Nasdaq Capital Market under the symbol IKNX. For investment and stock information contact: JON GERLACH Chief Financial Officer IKONICS Corporation 4832 Grand Avenue, Duluth, MN 55807 Phone: (218) 628-2217 email: jgerlach@ikonics.com TRANSFER AGENT WELLS FARGO SHAREOWNER SERVICES PO Box 64854 St. Paul, MN 55164-0854 Shareholders with questions on stock holdings, transfer requirements and address changes contact Wells Fargo Bank at: (800) 468-9716 AUDITOR MCGLADREY LLP 801 Nicollet Mall, Suite 1100 West Tower Minneapolis, MN 55802 (612) 573-8750 COUNSEL HANFT FRIDE 1000 U.S. Bank Place 130 W. Superior Street Duluth, MN 55802 (218) 722-4766 18 IKONICS CORPORATION | 2013 ANNUAL REPORTboard of directorS corporate officerS CHARLES H. ANDRESEN Attorney Hanft Fride Duluth, MN WILLIAM C. ULLAND Chairman, President & CEO Director Since 1979 CLAUDE PIGUET Executive Vice President LOCKWOOD CARLSON President Carlson Consulting Group JON GERLACH Vice President, Finance, CFO Minneapolis, MN Director Since 2009 RONDI C. ERICKSON Chief Executive Officer (retired 2006) PARNELL THILL Vice President, Marketing Apprise Technologies, Inc. Duluth, MN Director Since 2000 ROBERT D. BANKS Vice President, International ERNEST M. HARPER, JR. Chief Tax Officer (retired 2010) KEN HEGMAN Vice President, Sales: North America DAVID O. HARRIS General Mills, Inc. Minneapolis, MN Director Since 2012 President David O. Harris, Inc Minneapolis, MN Director Since 1965 DARRELL B. LEE Vice President, Chief Financial Officer, Treasurer, Secretary MOCON, Inc. Minneapolis, MN Director Since 2012 H. LEIGH SEVERANCE President Severance Capital Management Denver, CO Director Since 2000 GERALD W. SIMONSON President Omnetics Connector Corporation Minneapolis, MN Director Since 1978 WILLIAM C. ULLAND Chairman, President & CEO IKONICS Corporation Duluth, MN Director Since 1972 19 19 $18,000,000 $16,000,000 $14,000,000 $12,000,000 $10,000,000 $8,000,000 $6,000,000 $4,000,000 $2,000,000 $0 Net Sales 2009 – 2013 Net Income (Loss) 2009 – 2013 $1,400,000 $1,200,000 $1,000,000 $800,000 $600,000 $400,000 $200,000 $0 - $200,000 - $400,000 2009 2010 2011 2012 2013 2009 2010 2011 2012 2013 IKONICS Five-Year History 2009 2010 2011 2012 2013 Net Sales Pretax Income (Loss) Net Income (Loss) $15,121,617 $16,517,338 $16,780,262 $17,312,407 $17,491,408 $(11,360) $1,553,920 $1,043,257 $1,044,931 $927,173 $(307,360) $1,113,920 $698,257 $693,931 $682,173 Net Cash Provided by Operations $1,374,114 $1,601,369 $793,532 $1,181,950 $1,466,532 Return on Sales Return on Assets Return on Avg. Stockholders' Equity Debt to Equity Diluted EPS Stock price: High Low Close (2.0%) (2.6%) (2.7%) 8.8% $(0.16) $8.29 $4.00 $6.30 6.7% 8.5% 9.6% 7.8% $0.56 $8.00 $6.30 $7.25 4.2% 4.9% 5.5% 9.1% $0.35 $8.94 $6.90 $7.57 4.0% 5.3% 5.6% 11.8% $0.35 $9.45 $7.03 $8.05 3.9% 4.9% 5.6% 11.1% $0.34 $19.45 $7.92 $14.75 Weighted Average Common Shares Outstanding - Diluted 1,973,739 1,973,447 1,986,041 1,990,847 2,010,659 Total Assets Total Liabilities Total Stockholders' Equity Capital Spending $11,997,272 $13,141,931 $14,167,458 $13,184,276 $14,001,803 $971,186 $948,984 $1,176,915 $1,389,531 $1,401,985 $11,026,086 $12,192,947 $12,990,543 $11,794,745 $12,599,818 $90,313 $189,150 $621,598 $566,519 $762,537 4832 Grand Avenue Duluth, MN 55807 ph: (218) 628-2217 toll-free: (800) 328-4261 e: info@ikonics.com web: www.ikonics.com 

Continue reading text version or see original annual report in PDF format above